PRESS RELEASE published on 05/08/2025 at 09:12, 1 year 1 month ago Cherry SE and Contour Design agreed on the transition of CHERRY’s hygiene peripherals business Cherry SE and Contour Design agree on the strategic transition of CHERRY's hygiene peripherals business, enhancing Contour Design's position in specialized sectors Acquisition Strategic Partnership Cherry SE Contour Design Hygiene Peripherals
BRIEF published on 05/08/2025 at 09:08, 1 year 1 month ago Cherry SE Sells Hygienic Input Devices Business to Contour Design Cherry SE Business Sale Transaction Details Contour Design Hygienic Devices
BRIEF published on 05/08/2025 at 09:08, 1 year 1 month ago Cherry SE vend son activité de périphériques d'entrée hygiéniques à Contour Design Cerise SE Vente D'entreprise Détails De La Transaction Conception De Contours Dispositifs D'hygiène
PRESS RELEASE published on 05/08/2025 at 09:03, 1 year 1 month ago EQS-Adhoc: Cherry SE: Sale of the Hygienic Input Devices Business to Contour Design Cherry SE sells Hygienic Input Devices Business to Contour Design for EUR 12.5 million with additional variable component. Transaction expected to close in Q2 2025 Cherry SE Sale Contour Design Hygienic Input Devices EUR 12.5 Million
BRIEF published on 04/30/2025 at 09:29, 1 year 1 month ago Cherry SE Delays 2024 Annual Report Publication Cherry SE Restructuring Annual Report Audit Publishing Delay
BRIEF published on 04/30/2025 at 09:29, 1 year 1 month ago Cherry SE retarde la publication de son rapport annuel 2024 Restructuration Audit Rapport Annuel Cerise SE Retard De Publication
PRESS RELEASE published on 04/30/2025 at 09:24, 1 year 1 month ago New publication date for the annual report of Cherry SE Cherry SE's 2024 annual report publication postponed due to restructuring implications. New date for Q1 report release available on 14 May 2025 Cherry SE Restructuring Annual Report Postponement Q1 Report
BRIEF published on 04/29/2025 at 08:35, 1 year 2 months ago Les performances de Cherry SE au premier trimestre 2025 sont conformes aux attentes EBITDA Ajusté Baisse Des Revenus Opportunités De Croissance Cerise SE Résultats Du Premier Trimestre 2025
BRIEF published on 04/29/2025 at 08:35, 1 year 2 months ago Cherry SE's Q1 2025 Performance Aligns with Expectations Adjusted EBITDA Growth Opportunities Cherry SE Revenue Decline Q1 2025 Results
PRESS RELEASE published on 04/29/2025 at 08:30, 1 year 2 months ago Cherry SE publishes selected preliminary key figures for the first quarter of 2025 – in line with budget and, as planned, below the prior-year quarter Cherry SE reports Q1 2025 financial results below prior year but in line with budget. Revenue at EUR 25.3 million, EBITDA margin -8.0% Financial Results Revenue EBITDA Margin Cherry SE Q1 2025
Published on 06/29/2026 at 23:46, 18 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 2 hours 3 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 9 hours 4 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 9 hours 4 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 9 hours 34 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 22:47, 1 hour 16 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 1 hour 59 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 1 hour 59 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 3 hours 34 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 4 hours 3 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 5 hours 34 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 5 hours 34 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 6 hours 19 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 6 hours 19 minutes ago Déclaration hebdomadaire de rachat d'actions
